Jamieson advised CEO Sibylle Stauch-Eckmann and the Ober Scharrer Management Team on their equity incentive arrangements in the new structure and their re-investment alongside Nordic Capital.
OSG, is a recognised innovator in the field of ophthalmology, providing state-of-the-art medical care to both public and private patients. The Group specialises in eye surgeries with more than 90,000 surgical procedures performed annually.
Nordic Capital Fund IX acquired OSG in April 2018. The ambition is to support the further development of OSG in line with its current strategy of providing innovative medical care of the highest quality.
The team was advised by Stuart Coventry, Karin Himmelreich and Laura Yell.
